Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-16

Clinical Trial Update: Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Treatment of Non-muscle Invasive Bladder Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial in recruitment evaluating how patient positioning and intravesical dwell time of Bacillus Calmette-Guérin affect treatment for non-musc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bacillus Calmette-Guérin (Bacillus Calmette-Guérin)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Non-Muscle Invasive Bladder Carcinoma | Phase 4 | Status: RECRUITING